Bcl-2 family proteins and ICE/CED-3 family proteases (caspases) are regarded as the basic regulators of apoptotic cell death. They are evolutionarily conserved and implicated in a variety of apoptosis. However, the precise mechanism by which these two families interact to regulate cell death is not yet known. In this study, we found that the overexpression of the Bcl-2 family member Bax induced apoptotic cell death in COS-7 cells through the activation of CPP32 (caspase-3)-like proteases that cleaved the DEVD tetrapeptide. This apoptotic cell death was suppressed by the viral proteins CrmA and p35, as well as by the chemically synthesized caspase inhibitors Z-Asp-CH 2 -DCB and zVAD-fmk. We also found that the Bax-induced apoptosis of COS-7 cells was suppressed by Bcl-x L and Bcl-2, though both Bcl-x L and Bcl-2 similarly prevented etoposide-induced apoptosis in COS-7 cells. In addition, Bcl-x L inhibited the activation of caspase-3-like proteases accompanying Bax-induced COS-7 cell death but Bcl-2 did not. These results indicate that the caspase activation is essential for Bax-induced apoptosis, and that the ability of Bcl-2 and Bcl-x L to prevent the Bax-induced caspase activation and apoptosis in COS-7 cells could be dierentially regulated. Our results also suggest that Bcl-2 family proteins function upstream of caspase activation and control apoptosis through the regulation of caspase activity.
Introduction
Programmed cell death, or apoptosis, plays an essential role in the maintenance of the homeostasis of multicellular organisms, and accumulating evidence indicates that Bcl-2 family proteins and interleukin1b-converting enzyme (ICE)/CED-3 family cysteine proteases (caspases) are the major regulators of the cell death program (Jacobson et al., 1997) . With the goal of identifying the mechanism of cell death regulation, eorts have been made to de®ne the molecular order of the function of the Bcl-2 family and the caspase family. Earlier studies revealed that Bcl-2 can inhibit the apoptosis induced by active caspases (Martin et al., 1995; Enari et al., 1995) , while more recent studies demonstrated that Bcl-2 and other antiapoptotic Bcl-2 family members, Bcl-x L and adenovirus E1B 19K, suppress apoptosis by inhibiting processing and activation of caspases (Armstrong et al., 1996; Boulakia et al., 1996; Chinnaiyan et al., 1996; Cosulich et al., 1996; Erhardt and Cooper, 1996; Ibrado et al., 1996; Jacobson et al., 1996; Monney et al., 1996; Shimizu et al., 1996; Perry et al., 1997; Estoppey et al., 1997) . Although many studies have investigated antiapoptotic Bcl-2 family members, studies examining the step at which proapoptotic Bcl-2 family members function in the apoptotic signaling pathway are apparently lacking. Since the ratio of the antiapoptotic to proapoptotic Bcl-2 family members within a cell is thought to determine the susceptibility of the cells to death (Yang and Korsmeyer, 1996) , the molecular ordering of the proapoptotic Bcl-2 family proteins and caspase activation in the cell death pathway is of importance to the clari®cation of the mechanism of cell death regulation by the Bcl-2 family.
To understand how proapoptotic and antiapoptotic members regulate caspase activity and apoptosis, we established an experimental system in this study in which the overexpression of Bax, a proapoptotic member of the Bcl-2 family, induces apoptosis in COS-7 cells. Using this sytem, we observed that Bax regulates apoptotic cell death through the regulation of caspase activity. We also found that Bcl-x L but not Bcl-2 suppresses the caspase activation and apoptosis in COS-7 cells induced by Bax. These results support a model whereby both antiapoptotic and proapoptotic members of the Bcl-2 family function upstream of caspase activation and control cell's susceptibility to apoptosis through the regulation of caspase activity. Our results also point to distinct roles of Bcl-2 and Bclx L in the regulation of Bax-induced apoptosis.
Results

Overexpression of Bax induces apoptosis in COS-7 cells
To investigate the mechanism by which the proapoptotic Bcl-2 family protein Bax regulates cell death, we established an experimental system using COS-7 cells in which Bax expression alone can induce cell death in the absence of additional internal or external apoptotic stimuli that activate the apoptotic program. COS cells Chromosomal DNAs were extracted 48 h after transfection from total cells in the pcDNA3-and pcDNA3mbaxAS-transfected dishes (lanes 1 and 3, respectively) and from detached cells in the pcDNA3mbax-transfected dish (lane 2), and analysed on a 2.0% agarose gel. (d) Quantitation of apoptosis. Cells were transfected as in a, and the number of apoptotic cells in each transfected dish was determined as described in Materials and methods 48 h after transfection. Data indicate the mean and standard deviation from a representative experiment done in duplicate. (e) Bax protein is overexpressed selectively in the apoptotic cells. Cells were transfected as in a, and cell lysates were prepared 48 h after transfection. Cell lysates were prepared separately from adherent (lane 2) and detached (lane 3) cells transfected with pcDNA3mbax. Lysates were resolved by 15% SDS ± PAGE and subjected to immunoblot analysis using anti-Bax polyclonal antibody derived from the transformation of simian CV-1 cells with an origin-defective simian virus 40 (SV 40) genome are suitable for the transient high-level expression of transgenes. COS cells are also known to be resistant to cell death induced by ICE or serum deprivation, which may be explained in part by the increased secretion of IGF-1 mediated by SV40 large T antigen (Sambrook et al., 1989; Jung et al., 1996) . We tested in this study whether Bax overexpression alone can induce cell death in COS cells. When COS-7 cells were transiently transfected with a plasmid vector that drives the expression of mouse bax cDNA and were maintained in normal culture conditions, the cells began to die and detach from the dish approximately 24 h after the transfection, and numerous¯oaters were observed at 48 h after the transfection (Figure 1a , middle). Acridine orange staining of these¯oaters revealed condensed and/or fragmented nuclei, suggesting that these cells were dying by apoptosis ( Figure  1b ). The apoptotic nature of their death was further con®rmed by the identi®cation of the oligonucleosomal fragmentation of the chromosomal DNA extracted from these cells ( Figure 1c ). Figure 1d shows that the transfection of the bax-expressing plasmid produced a signi®cantly increased number of apoptotic cells compared to the transfection of an empty expression vector or vector plasmid expressing the antisense mouse bax mRNA (see also Figure 1a ), indicating that the apoptotic cell death and eventual detachment of the cells from the dish was caused in a Bax expression-dependent manner. To verify whether the apoptotic death of COS-7 cells was actually attribu- Using the above established system, we next examined whether caspases have a critical role in the apoptosis induced by Bax. Poxvirus CrmA protein and baculovirus p35 protein have been shown to suppress apoptosis by inhibiting the protease activity of caspases (Ray et al., 1992; Gagliardini et al., 1994; Bump et al., 1995; Tewari et al., 1995; Xue and Horvitz, 1995) . It has been reported that CrmA inhibits the protease activity of some (ICE, Mch5 (caspases-1 and 8)) but not other Mch2, Mch3, 6, 7, 10) and CED-3) caspases, whereas p35 inhibits the protease activity of all the caspases tested including ICE, ICH-1, CPP32, ICH-2 (caspases-1, 2, 3, 4) and CED-3 in vitro (Ray et al., 1992; Wang et al., 1994; Bump et al., 1995; Fernandes-Alnemri et al., 1995; Xue and Horvitz, 1995; Srinivasula et al., 1996) . We coexpressed these viral proteins together with Bax and examined their eects on Bax-induced apoptosis. As shown in Figure 2 , the cotransfection of CrmA-or p35-expressing plasmid into COS-7 cells together with Bax-expressing plasmid reduced the number of apoptotic cells by *50% compared to the cotransfection of Bax-expressing plasmid with a control plasmid. This result indicates that both CrmA and p35 can suppress Bax-induced apoptosis, and therefore suggests that CrmA-and p35-inhibitable caspases are involved in Bax-induced apoptosis of COS-7 cells.
CPP32 (caspase-3)-like protease activity is induced in cells undergoing Bax-induced apoptosis
We next characterized the caspases which are involved in the bax-induced apoptosis. Using the tetrapeptide substrates acetyl-Tyr-Val-Ala-Asp a-(4-methyl-coumaryl-7-amide) (Ac-YVAD-MCA) and Ac-Asp-Glu-ValAsp (DEVD)-MCA, which are speci®cally cleaved by caspases-1 and 3, respectively (Enari et al., 1996) , we measured the ICE (caspase-1)-like and CPP32 (caspase-3)-like protease activities in cell lysates during Baxinduced apoptosis. For this, cell lysates were prepared from total cells transfected with an empty vector plasmid or Bax-expressing plasmid. Cell lysates were also prepared separately from adherent (live) and detached (apoptotic) cells transfected with the Bax-expressing plasmid. When these cell lysates were assayed for caspase-1-like protease activity at 48 h after transfection, no signi®cant increase was detected in the lysate prepared from cells undergoing Bax-induced apoptosis compared with the other lysates ( Figure 3a ). This result suggests that caspase-1-like proteases cleaving the tetrapeptide sequence YVAD may not be involved in Bax-induced apoptosis of COS-7 cells, or alternatively, that caspase-l-like protease activity may be only transiently induced during apoptosis caused by Bax overexpression in COS-7 cells. In contrast, when the cell lysates were assayed for caspase-3-like protease activity using the tetrapeptide substrate Ac-DEVD-MCA, the caspase-3-like protease activity in the lysate prepared from total (both adherent and detached) cells transfected with Bax-expressing plasmid ( Figure 3b , lane 2) was approximately twice as high as that of the control cell lysate (lane 1). A considerable increase in caspase 3-like protease activity (sevenfold increase relative to vector control) was detected in the lysate prepared from Baxexpressing apoptotic cells ( Figure 3b , lane 3), but caspase-3-like protease activity was only marginally increased relative to control in the lysate prepared from Bax-transfected but adherent cells (hence non-apoptotic and expressing only a low level of Bax protein; Figure 3b , lane 4). These results indicate that caspase-3-like protease activity is induced in close association with Bax-induced apoptosis in COS-7 cells.
Caspase activation plays an essential role in the apoptosis induced by Bax
The result that caspase-3-like protease activity is increased in close association with Bax-induced apoptosis, together with the ®nding that Bax-induced apoptosis is inhibitable by CrmA and p35, suggested that caspases, possibly caspase-3-like proteases, play a key role in the Bax apoptotic pathway. To test this possibility, we examined the eect of inhibiting the caspase-3-like protease activity on Bax-induced apoptosis. Z-Asp-CH 2 -DCB is a speci®c caspase inhibitor that can easily penetrate the cell membrane (Dolle et al., 1994; Mashima et al., 1995) . We con®rmed the inhibitory activity of this compound on the caspase-3-like protease activity induced by Bax in vitro. When the caspase-3-like protease activity in the apoptotic cell lysate was measured in the presence of varying concentrations of Z-Asp-CH 2 -DCB, the activity was inhibited in a concentration-dependent manner, with 50% inhibition achieved at approximately 0.5 mM (Figure 4a ). To test whether Z-Asp-CH 2 -DCB can inhibit caspase-3-like protease activity in vivo as well, we added Z-Asp-CH 2 -DCB to the culture medium after the transfection of the Bax-expressing plasmid into COS-7 cells and measured caspase-3-like protease activity in the cell lysates prepared 48 h after transfection. As Figure 4b shows, Z-Asp-CH z -DCB added to the culture medium inhibited the activation of caspase-3-like proteases in a concentration-dependent manner, albeit at a much higher concentration than that observed in vitro. We then examined the eect of inhibiting the activation of caspase-3-like proteases by Z-Asp-CH 2 -DCB on Bax-induced apoptosis. As shown in Figure 4c , the addition of Z-Asp-CH 2 -DCB to the culture medium inhibited the Bax-induced apoptosis in COS-7 cells in a concentration-dependent manner, and the degree of apoptosis inhibition was in agreement with the degree of inhibition of the caspase-3-like protease activity. To examine the possibility that ZAsp-CH 2 -DCB inhibits Bax-induced apoptosis by suppressing Bax expression, we determined the eect of Z-Asp-CH 2 -DCB on Bax protein expression by immunoblot analysis. Figure 4d demonstrates that ZAsp-CH 2 -DCB enhanced but never suppressed the COS-7 cells were transfected with 5 mg of pcDNA3 empty vector or pcDNA3mbax. The transfection of pcDNA3mbax was done in duplicate. Total cells were collected 48 h after transfection from the vector-transfected dish (Vector) and from one of the baxtransfected dishes (Bax, total). Detached (Bax, detached) and adherent (Bax, adherent) cells were separately collected from the other bax-transfected dish. Cell lysates were prepared and assayed for YVAD-cleaving (a) and DEVD-cleaving (b) protease activities. Data indicate the mean and standard deviation from expression level of Bax in COS-7 cells. We also tested the eect of benzoxy-carbonyl-Val-Ala-Asp-fluoromethylketone (zVAD-fmk), another small peptidebased, commonly used caspase inhibitor that penetrates the cell membrane (Armstrong et al., 1996; Jacobson et al., 1996) , on Bax-induced apoptosis. As shown in Figure 4e , zVAD-fmk also suppressed Baxinduced apoptosis in COS-7 cells in a concentrationdependent manner. Taken together, these results strongly suggest that the activation of caspases, possibly caspase-3-like proteases, is a critical step in the Bax-mediated apoptotic pathway. Recently, Xiang et al., (1996) reported that zVAD-fmk inhibited the Bax-induced activation of caspase-3-like proteases but not the membrane permeability death of Jurkat cells determined by dye exclusion test. We therefore examined whether Z-Asp-CH 2 -DCB and zVAD-fmk inhibit the membrane-permeability death of COS-7 cells induced by Bax. Figure 4f clearly indicates that the membrane-permeability death induced by Bax expression was suppressed by nearly 80% in the presence of 60 mM Z-Asp-CH z -DCB or zVAD-fmk. Thus, in COS-7 cells, the activity of caspases is apparently required for the induction of cell death by Bax.
Dierential eects of Bcl-2 and Bcl-x L on the Baxinduced activation of caspase-3-like proteases and apoptosis
It has been shown that Bax can antagonize the antiapoptotic eects of Bcl-2 and Bcl-x L (Oltvai et al., 1993 , Simonian et al., 1996 . Regarding the mechanism of apoptosis regulation by Bcl-2 family members, it is In vivo inhibition of caspase-3-like protease activity by Z-Asp-CH 2 -DCB. COS-7 cells were transfected with 5 mg of pcDNA3mbax, and Z-Asp-CH 2 -DCB was added to the culture medium 6 h after the transfection at the indicated concentrations. Cell lysates were prepared from total cells 48 h after the transfection and assayed for DEVD-cleaving protease activity. The graph shows the relative DEVDcleaving activity, and data indicate the mean and standard deviation from two separate experiments. (c) Inhibition of Bax-induced apoptosis by Z-Asp-CH 2 -DCB. Cells were treated as in b, and the number of apoptotic cells in each dish was determined as described in Materials and methods 48 h after the transfection. The graph shows the relative number of apoptotic cells compared with the number of cells undergoing apoptosis in the absence of Z-Asp-CH 2 -DCB (0 mM). Data indicate the mean and standard deviation from two separate experiments. (d) Eect of Z-Asp-CH 2 -DCB on Bax expression. COS-7 cells were treated as in b, and cell lysates were prepared from total cells 48 h after the transfection. Cell lysates were resolved by 15% SDS ± PAGE and subjected to immunoblot analysis using Bax polyclonal antibody. (e) Inhibition of Bax-induced apoptosis by zVAD-fmk. COS-7 cells were transfected with 5 mg of pcDNA3mbax, and zVAD-fmk was added to the culture medium 6 h after the transfection at the indicated concentrations. The number of apoptotic cells in each dish was determined as described in Materials and methods 48 h after the transfection, and the graph shows the relative number of apoptotic cells. Data indicate the mean and standard deviation from two separate experiments. (f) Inhibition of Bax-induced membrane-permeability death by Z-Asp-CH 2 -DCB and zVAD-fmk. Cells were transfected with 5 mg of either pcDNA3 or pcDNA3mbax in duplicate, and one set received either of the peptide inhibitors (60 mM) at 6 h after transfection. At 48 h after the transfection, dead cells were counted by the trypan blue dye exclusion method, and the number of Bax-speci®c dead cells in each dish was determined as described in Materials and methods. The graph shows the relative number of Bax-speci®c dead cells in the presence (60 mM) of peptide inhibitors compared to the number of Bax-speci®c dead cells in their absence (0 mM). The results are the mean and standard deviation from three (Z-Asp-CH 2 -DCB) and two (zVAD-fmk) separate experiments Bax+Bcl-2 LacZ+Bcl-2 Bax+Bcl-xL LacZ+Bcl-xL Figure 5 The ability of Bcl-2 and Bcl-x L to inhibit the Baxinduced activation of caspase-3-like proteases and apoptosis can be dierentially regulated. (A) Eect of Bcl-2 and Bcl-x L expression on Bax-induced apoptosis. COS-7 cells were transfected with combinations of 2.5 mg pcDNA3mbax and 2.5 mg pcDNA3 (Bax+Vector), pcDNA3bc12 (Bax+Bcl-2), or pcDNA3mbclx L (Bax+Bcl-x L ). The number of apoptotic cells in each transfected dish was determined as described in Materials and methods 48 h after the transfection. The graph indicates the relative number of apoptotic cells compared with (Bax+Vector). Data represent the mean and standard deviation from two separate experiments. (b) Expression levels of Bax, Bcl-2, and Bclx L in transfected cells. Cells were transfected as in a, and cell lysates were prepared from total cells 48 h after the transfection. Cell lysates were resolved by 15% SDS ± PAGE and immunoblotted with polyclonal antibodies for Bax (upper), Bcl-2 (middle), and Bcl-x (lower). (c) Bcl-2 and Bcl-x L similarly protect COS-7 cells from etoposide-induced cell death. Cells were transfected in duplicate with 2.5 mg of either pcDNA3 (Vector), pcDNA3bc12 (Bcl-2), or pcDNA3mbcl-x L (Bcl-x L ) together with 2.5 mg of marker plasmid encoding the lacZ gene; one set received etoposide treatment 24 h after the transfection, and the other set was left untreated. Viability was assessed 48 h after the transfection, as described in Materials and methods. The graph shows the normalized viability with that of vector control set to 1, and the values are the mean and standard deviation from three separate experiments. (d) Expression levels of Bcl-2 and Bcl-x L are not altered either in the presence of overexpressed Bax or bgalactosidase, a marker protein. COS-7 cells were transfected with 2.5 mg pcDNA3mbax+2.5 mg pcDNA3mbcl2 (lane 1), 2.5 mg pcDNA3lacZ+2.5 mg pcDNA3bcl2 (lane 2), 2.5 mg pcDNA3mbax+2.5 mg pcDNA3mbclx L (lane 3), or 2.5mg pcDNA3lacZ+2.5 mg pcDNA3bclx L (lane 4), and cell lysates were prepared 24 h after the transfection. The lysates were resolved by 15% SDS ± PAGE and immunoblotted with anti-Bcl-2 (lanes 1, 2) and anti-Bcl-x (lanes 3, 4) antibodies. (e) Eect of Bcl-2 and Bclx L expression on Bax-induced activation of caspase-3-like proteases. Cells were transfected as in a. Cell lysates were prepared from total cells 48 h after the transfection and then assayed for DEVD-cleaving protease activity. The DEVD-cleaving activity in a cell lysate prepared from exponentially growing COS-7 cells (COS-7) is also shown. Data indicate the mean and standard deviation from two separate experiments of great interest to know whether Bcl-2 and Bcl-x L can antagonize the proapoptotic function of Bax. Although Bcl-2 and Bcl-x L have been shown to suppress the lethal function of Bax in yeast cells (Sato et al., 1994; Hanada et al., 1995; Greenhalf et al., 1996) , this issue has not been suciently addressed in mammalian cells, probably due to the limited number of suitable experimental systems. We therefore examined in this study whether Bcl-2 and Bcl-x L can inhibit Bax-induced apoptosis in COS-7 cells. As Figure 5a shows, the coexpression of Bcl-x L signi®cantly suppressed the apoptosis induction by Bax. However, in our assay condition, Bcl-2 repeatedly failed to reduce the number of apoptotic cells induced by Bax. Since Bcl-2 has been shown to increase the steady-state level of Bax protein by preventing its degradation in some cell lines (Miyashita et al., 1995) , we examined whether or not the apparent failure of apoptosis inhibition by Bcl-2, as well as the apoptosis inhibition by Bcl-x L , were merely the consequences of altered Bax protein expression caused by the coexpression of these proteins. As demonstrated in Figure 5b , the expression level of Bax protein remained unchanged even in the presence of an apparent overexpression of Bcl-2 (lane 2) and Bcl-x L (lane 3) in COS-7 cells. It was also possible that Bcl-2 was not fully functional in COS-7 cells due to, for instance, an insucient expression of some cooperating molecules such as Bag-1 and Raf-1 (Takayama et al., 1995; Wang et al., 1996a) . To test this possibility, we examined whether Bcl-2 could suppress etoposide-induced apoptosis in COS-7 cells, since both Bcl-2 and Bcl-x L have been shown to have inhibitory activities against the apoptosis induced by this chemotherapeutic agent (Dole et al., 1994; Kondo et al., 1994; Minn et al., 1995; Simonian et al., 1996) . The results indicated that Bcl-2 was almost equally protective as Bcl-x L against etoposide-induced COS-7 cell death (Figure 5c ). We con®rmed by immunoblot analysis that the expression levels of Bcl-2 and Bcl-x L were not altered irrespective of whether they were coexpressed with Bax or with a transfection marker protein b-galactosidase (Figure 5d ). Together, these results suggest that Bcl-x L can eciently inhibit Baxinduced apoptosis whereas the antiapoptotic function of Bcl-2 is substantially compromised in the presence of Bax overexpression. To further investigate how Bax, Bcl-2 and Bcl-x L control apoptosis, we next examined the eect of Bcl-2 and Bcl-x L expression on the Baxinduced activation of caspase-3-like proteases. As shown in Figure 5e , Bcl-x L suppressed the activation of caspase-3-like proteases induced in COS-7 cells by Bax overexpression whereas Bcl-2 did not, suggesting that their ability to regulate Bax-induced apoptosis correlates with their ability to regulate the Bax-induced activation of caspase-3-like proteases.
Discussion
In this study, we established a model experimental system in which the overexpression of the proapoptotic protein Bax induces apoptosis in COS-7 cells. Using this system, we demonstrated that caspase-3-like protease activity is increased in a Bax expressiondependent manner, indicating that Bax acts upstream of the caspase-3-like proteases and regulates their activity. Our experiments with caspase inhibitors such as CrmA, p35, Z-Asp-CH 2 -DCB and zVAD-fmk suggested that caspase activation is essential for the induction of apoptosis by Bax. Although we cannot exclude the possibility that caspases other than caspase-1 and 3-like proteases are also involved in Bax-induced apoptosis, it is likely that caspase-3-like proteases play an essential role in Bax-induced apoptosis. In support of our ®nding, Wang et al. (1996b) recently reported that the apoptosis induced by Bid, another proapoptotic Bcl-2 family member, was also suppressed by zVAD-fmk, although it was not shown in their study whether and which caspases were activated by Bid expression.
During preparation of this manuscript, Xiang et al. (1996) reported that Bax expression without another death stimulus induced caspase-3-like protease activation and apoptosis in Jurkat cells. In their study, caspase-3-like protease activity but not caspase-1-like activity was induced during Bax-induced apoptosis, consistent with our results suggesting that Bax regulates caspase-3-like but not caspase-1-like protease activity. However, surprisingly, zVAD-fmk which inhibited the activation of caspase-3-like proteases, failed to inhibit the membrane-permeability death of Jurkat cells induced by Bax. Their data indicated that zVAD-fmk completely inhibited the DNA fragmentation and, though partially, chromatin condensation and membrane blebbing induced by Bax. These results suggest that Bax may activate two independent cell death pathways, one leading to apoptotic cell death mediated by zVADfmk-inhibitable caspases and the other leading to membrane-permeability cell death which is insensitive to zVAD-fmk. Contrary to their results, our study showed that both Z-Asp-CH 2 -DCB and zVAD-fmk inhibited the membrane-permeability death as well as apoptotic death of COS-7 cells induced by Bax. this discrepancy may be attributable to the relative dominance of the two independent cell death pathways, which may vary from cell line to cell line. Although further studies are certainly warranted to establish the roles of the apoptotic cell death pathway and the membrane-permeability cell death pathway in Baxinduced cell death, it is clear that Bax acts upstream of caspase-3-like proteases and regulates their activity.
Although we have shown that caspase-3-like protease activity is induced during Bax-induced apoptosis, the mechanism of caspase activation by Bax remains unknown. Recently, it has been reported that the release from the mitochondria of cytochrome c capable of activating caspase-3 and/or apoptosisinducing factor (AIF) having zVAD-fmk-inhibitable proteolytic activity, plays an important role in apoptotic signaling and that Bcl-2 can inhibit this process (Susin et al., 1996; Yang et al., 1997; Kluck et al., 1997) . Bcl-x L has been shown to interact indirectly with ICE and FLICE (caspases-1 and 8) through association with the putative mammalian homolog of CED-4, suggesting that this complex formation might have a functional role in the regulation of caspase activation (Chinnaiyan et al., 1997) . It can therefore be speculated by inference that Bax may induce caspase-3-like protease activation through modulation of the cytochrome c and/or AIF release from the mitochondria or through modulation of the complex formation by antiapoptotic Bcl-2 family members, the putative mammalian CED-4 homolog, and caspases. Our present system using COS cells may serve as a useful tool to test these possibilities and to elucidate the molecular mechanism of Bax-induced activation of caspase-3-like proteases.
Another important ®nding obtained in this study is that the apoptosis induced by Bax overexpression was dierentially regulated by Bcl-2 and Bcl-x L as suppressors of apoptosis. It has been shown that the ability of Bcl-2 to heterodimerize with Bax is inseparable from its antiapoptotic function, whereas the interaction with Bax is not required for Bcl-x L to exert its antiapoptotic function Cheng et al., 1996) . In addition, Simonian et al. (1996) reported that the interaction with Bcl-x L is not required for Bax to antagonize the antiapoptotic function of Bcl-x L . These lines of evidence suggest that Bax and Bcl-x L exert their proapoptotic and antiapoptotic functions independently from heterodimer formation although they can interact with each other to form heterodimers (Cheng et al., 1996; Simonian et al., 1996) . If this is the case, our results would indicate that Bcl-x L functions downstream of Bax and counteracts the death signal coming down from Bax to activate caspase-3-like proteases. However, contrary to Bcl-x L , Bcl-2 failed to inhibit the apoptosis induced by Bax overexpression. This ®nding is consistent with the observation reported by Gottschalk et al. (1996) that Bcl-x L but not Bcl-2 was protective against apoptotic stimuli in WEHI-231 cells that express a high level of endogenous Bax. One possible explanation for the apparent inability of Bcl-2 to inhibit apoptosis in the presence of Bax overexpression is that Bcl-2 cannot counteract the death signal elicited by Bax. However, this might not be an appropriate explanation since Bcl-2 has been shown to suppress Bax-induced apoptosis in another cell line (Hunter and Parslow, 1996) . Therefore, it is likely that Bcl-2 inhibits apoptosis by binding and inactivating Bax but only when Bcl-2 exists at a considerable excess molar concentration relative to Bax.
As demonstrated in this study, Bax, a proapoptotic member of the Bcl-2 family, can induce apoptosis in COS-7 cells through the activation of caspases, while Bcl-x L , an antiapoptotic Bcl-2 family member, inhibits the Bax-induced apoptosis by inhibiting caspase activation. These ®ndings support a model whereby Bcl-2 family proteins regulate apoptosis through a modulation of the caspase activity. Even exponentially growing, healthy cells have basal caspase-3-like activity as exempli®ed by the COS-7 cells used in this study. Although it may be possible that this basal activity is derived from proteases irrelevant to cell death, there may be a threshold for caspase activity to induce cell death. If so, our results point to the possibility that the relative expression levels of proapoptotic and antiapoptotic members such as Bax, Bcl-2 and Bcl-x L regulate the level of caspase activity and by so doing determine the cell's sensitivity to various apoptotic stimuli.
Materials and methods
Cell culture and transfection
COS-7 cells were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) (Nissui) supplemented with 10% fetal calf serum (FCS) (Immuno Biological Laboratories), 100 units/ml of penicillin G and 100 mg/ml of streptomycin (Life Technologies), and 0.6 mg/ml glutamine (Nissui), at 378C in 5% CO 2 . The introduction of plasmid DNAs was accomplished by the lipofectin-mediated transfection method as previously described (Kitanaka et al., 1995) . Prior to transfection, COS-7 cells (2610 5 ) were seeded into 60-mm dishes and 18 h later, the medium was replaced with Opti-MEM I (Life Technologies) and the cells were incubated with lipofectin-treated plasmid DNAs (5 mg) for 6 h. Then, Opti-MEM I containing plasmid DNAs was removed and the cells were refed with DMEM containing 10% FCS. The peptide caspase inhibitors Z-Asp-CH 2 -DCB (Peptide Institute) and zVAD-fmk (Kamiya Biomedical Company) were used after being dissolved in DMSO (10 mM).
Plasmids pcDNA3mbax and pcDNA3mbaxAS were constructed by subcloning the EcoRI fragment of pSKmbax containing the mouse bax cDNA coding region into the EcoRI site of an expression vector pcDNA3 (Invitrogen) in the sense and antisense orientation to the cytomegalovirus promoter, respectively. For the construction of pcDNA3bc12, the KpnI ± XhoI fragment conaining the human bcl-2 cDNA coding region was excised from pCEP4bc12 and subcloned into the corresponding site of pcDNA3. pcDNA3mbclx L was constructed by subcloning the EcoRI fragment of pSKbcl-x L containing the mouse bcl-x L cDNA coding region into the EcoRI site of pcDNA3. For the construction of pcDNA3p35, the BamHI ± EcoRI fragment containing the coding region of p35 cDNA was excised from pcDL-SRap35 (a kind gift from Dr Yuko Murakami) and subcloned into the corresponding site of pcDNA3. pcDNA3crmA was constructed by subcloning the EcoRI fragment of pSKcrmA containing the crmA cDNA coding region (a kind gift from Dr David J Pickup) into the EcoRI site of pcDNA3.
Immunoblotting COS-7 cells were directly lysed in lysis buer (50 mM Tris-HCI (pH 8.0), 120 mM NaC1, 0.5% nonidet P-40, 100 mM PMSF, 2 mg/ml aprotinin) and equalized for protein contents. The protein samples were resolved in a 15% SDS-polyacrylamide gel and electrically transferred to a nitrocellulose membrane. The membrane was probed with appropriate primary antibodies (N-20 for Bax, N-19 for Bcl-2, S-18 for Bcl-x (Sants Cruz)) in antibody buer (PBS containing 5% non-fat milk and 0.1% Tween 20) for 2 h at room temperature. After being washed with antibody buer, the membrane was subsequently incubated with HRP-Rat Anti Rabbit IgG (ZYMED) as a secondary antibody for 1 h at room temperature. The membrane was then washed with antibody buer lacking non-fat milk, and bound antibodies were detected by ECL Western blotting detection reagents according to the manufacturer's protocol (Amersham).
Cell death assays
For the identi®cation and quantitation of apoptotic cells, cells detached from the dish were collected and suspended in PBS. An aliquot of the cell suspension was then mixed with an equal volume of 2 mg/ml acridine orange solution in PBS and examined under a¯uorescence microscope for condensed and/or fragmented nuclear morphology.
Oligonucleosomal DNA fragmentation was examined essentially as described by Evan et al. (1992) . In brief, detached cells were collected, and after being washed with PBS, suspended in 20 ml of PK buer (10 mM EDTA, 50 mM Tris-HCI (pH 8.0), 0.5% SDS and 0.5 mg/ml proteinase K). The samples were incubated at 558C for 2 h and further 2 h in the presence of 0.5 mg/ml RNase A (Sigma). The extracted DNAs were subjected to 2% agarose gel electrophoresis and the DNA bands were visualized by staining with ethidium bromide.
For the examination of membrane-permeability death, both detached and adherent cells were collected and suspended in PBS. An aliquot of the cell suspension was mixed with an equal volume of 0.3% trypan blue in PBS, and dead cells that did not exclude the dye were counted under a phase-contrast microscope. The number of Bax-speci®c dead cells was de®ned as (the number of dead cells in the baxtransfected dish) ± (the number of dead cells in the vectortransfected dish).
For the examination of the suppression of etoposideinduced cell death by Bcl-2 and Bcl-x L , COS-7 cells were transfected with expression plasmids together with pcDNA31acZ in duplicate, and one set received etoposide treatment (0.75 mg/ml) starting at 24 h after the transfection, while the other set was left untreated. At 48 h after the transfection, cells were ®xed in 0.2% glutaraldehyde and 2% formaldehyde for 5 min and stained in X-Gal buer (0.1% X-Gal, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 2 mM MgC1 2 in PBS) at 378C for 3 h. The numbers of blue cells in etoposide-treated dishes and untreated dishes were counted. Viability was calculated as (the number of blue cells in the etoposide-treated dish)/(the number of blue cells in the untreated dish).
Measurement of protease activity
Adherent and detached cells were collected either separately or together and lysed in lysis buer (10mM HEPES-KOH (pH 7.4), 2 mM EDTA, 0.1% CHAPS, 1 mM PMSF, 5 mM DTT) for 20 min on ice. After centrifugation, the supernatants were collected as lysates. For the measurement of protease activity, 10 mg of lysates diluted to 20 ml with lysis buer were mixed with 20 ml of 26 ICE buer (40 mM HEPES-KOH (pH 7.4), 20% (v/v) glycerol, 1 mM PMSF, 4 mM DTT) containing 40 mM tetrapeptide substrate Ac-DEVD-MCA or Ac-YVAD-MCA (Peptide Institute) and incubated at 378C for 1 h. After the addition of 1 ml of distilled water, thē uorescence of the reaction mixture was determined using a spectro¯uorometer. The excitation and emission wavelengths were 380 nm and 460 nm, respectively. One unit of protease activity was de®ned as the amount of enzyme required to release 1 pmol 7-amino-4-methylcoumarin (AMC) per min at 378C.
